Biotechnology News

September 8, 2014

LOS ANGELES--(BUSINESS WIRE)--Trifecta Clinical, a leading global provider of online clinical investigator training, is excited to announce the launch of Voices in Life Sciences (VLS) at the 2014 Disruptive Innovations in Boston. “Last year at...

September 8, 2014

PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that the Company has received approval from Brazilian National Health Surveillance Agency (ANVISA)...

September 8, 2014

BELMONT, Calif.--(BUSINESS WIRE)--LakePharma, a leading protein engineering contract research organization, is hosting its second annual Antibody Engineering Symposium this October 9th & 10th. The 2014 Symposium will be held at the South San...

September 8, 2014

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (Paris:IMPL), a medical technology company specializing in vertebral and knee-surgery implants, today announces the...

September 8, 2014

--(BUSINESS WIRE)--BIO and Biominas Brasil cohost the BIO Latin America Conference, the industry’s premier event for building innovation and collaboration in Latin America’s fast-growing biotechnology sector.

September 8, 2014

WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest Inc. today announced the appointment of Robert Hoyt as an independent director of the firm, effective immediately. Mr. Hoyt’s appointment expands the Board to six directors. “Bob’s enormous success...

September 8, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--Miles Orchinik, PhD, the School of Life Sciences at Arizona State University, named the 2014 Michael A. Cusanovich Arizona Bioscience Educator of the Year by AZBio

September 8, 2014

DURHAM, N.C.--(BUSINESS WIRE)--Novan Therapeutics, a clinical-stage biotech company focused on advancing nitric oxide therapies, announced today that Novan’s nitric oxide drug candidate SB206 was shown to inhibit papilloma growth in a preclinical...

September 8, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, announced today the launch of its Dyneema Purity® Radiopaque fiber, the only radiopaque ultra-high-molecular-weight-polyethylene (UHMWPE...

September 8, 2014

GRENOBLE, France--(BUSINESS WIRE)--Prof. Alim-Louis Benabid, chairman of the board of the French bio-medical research center Clinatec and member of the French Académie des Sciences, has been named co-winner of the prestigious 2014 Lasker~DeBakey...

September 8, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--September is Blood Cancer Awareness Month, and the MPN Coalition, a group of seven patient organizations, has designated September 11, 2014, as MPN Awareness Day. This day recognizes the approximately 300,000...

September 8, 2014

BOURNEMOUTH, England--(BUSINESS WIRE)--Solentim is pleased to announce the purchase of its Cell Metric™ CLD system for monoclonality verification by Horizon Discovery Group plc, which will use it as part of internal R&D projects.

September 8, 2014

SAN ANTONIO & COLUMBIA, Md.--(BUSINESS WIRE)--MedStar Health to Deploy AirStrip ONE for Labor and Delivery

September 8, 2014

DALLAS--(BUSINESS WIRE)--Perkins Healthcare Technologies is pleased to announce the selection of its Patient Observation & Fall Management Solution to be showcased at the 2014 Novation Innovative Technology Expo. The Expo will be held on...

September 8, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness announced positive results from the Company’s 42-week Functional Ambulation: Standard Treatment vs. Electrical Stimulation Therapy (FASTEST) trial of the Bioness L300® Foot Drop System.

September 8, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies, announced today that the US Food and Drug Administration (FDA) has...

September 8, 2014

BOSTON--(BUSINESS WIRE)--Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014

September 8, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present at Annual Meeting of the Association for Vascular Access (AVA)

September 8, 2014

MUNICH--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from the AMBITION study (a randomized, double-blind, multicenter study of first-line combination therapy with AMBrIsentan and Tadalafil in patients with...

September 8, 2014

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Edge Therapeutics today announced that it has obtained up to $10 million in venture debt financing from Hercules Technology Growth Capital, Inc. to support the continued development of EG-1962.

September 8, 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--LabCorp/ARCA biopharma joint personalized medicine poster selected for presentation at the 18th Annual Scientific Meeting of the Heart Failure Society of America

September 8, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that its multiple sclerosis pipeline, which includes a new generation of investigational treatments in early development, will be featured...

September 8, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment Conference

September 8, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced positive new data from Phase III studies of the company’s anti-IL5 monoclonal antibody, reslizumab, in patients with uncontrolled moderate to severe...

September 8, 2014

MUNICH, Germany--(BUSINESS WIRE)--Data from the pivotal phase III TONADO™ studies for tiotropium + olodaterol Respimat® FDC were presented for the first time today at the European Respiratory Society (ERS) International Congress 2014

September 8, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories will present at the Morgan Stanley Global Healthcare Conference on September 9, 2014 at 10:00 a.m. EDT

September 8, 2014

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that the Company is offering a warranty for its Endoskeleton® line of...

September 8, 2014

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. and the Tri-Institutional Therapeutics Discovery Institute announce software access agreement.

September 8, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech announced that it has achieved a $50 million enrollment milestone payment from Novartis as part of the ex-US licensing and commercialization agreement focused on the treatment of wet AMD.

September 8, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna® (imilecleucel-T), a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today disclosed that the...

September 8, 2014

DALLAS & CARY, N.C. & VERONA, Wis.--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos”), a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug delivery technologies as well as a late-stage pipeline of...

September 8, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that Robert Wild, Ph.D., has been appointed as Chief Scientific Officer and Senior Vice President, Research. “Robert...

September 8, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced that once-weekly BYDUREON® (exenatide extended-release for injectable suspension) Pen 2 mg, a prescription medicine, is now available in pharmacies across the United States...

September 8, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. raised approximately $7.5 Million upon exercise of certain old warrants by the warrant holders.

September 8, 2014

BOSTON & SEATTLE & HOUSTON & NEW YORK & SAN DIEGO--(BUSINESS WIRE)--World-renowned cancer centers and Illumina, Inc. (NASDAQ:ILMN) today announced the formation of the Actionable Genome Consortium (AGC), an effort to recommend...

September 8, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to asfotase alfa for the treatment of patients with hypophosphatasia (HPP).

September 8, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference

September 8, 2014

HELSINKI--(BUSINESS WIRE)--Ginolis Ltd delivers an additional point-of-care diagnostic production solution to the Swedish company Fiomi Diagnostics AB (owned by Trinity Biotech PLC, Ireland). The solution is used for dispensing reagents for the...

September 8, 2014

TOKYO--(BUSINESS WIRE)--Sosei Group Corporation (“Sosei”)(TOKYO:4565) confirms the new data from three clinical trials presented by Novartis at the European Respiratory Society (ERS) International Congress, September 6-10, in Munich, Germany. The...

September 7, 2014

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--CureDuchenne launched the “Dollar 4 Duchenne” campaign today during World Duchenne Awareness Day to fund research to find a cure for Duchenne muscular dystrophy. The “Dollar 4 Duchenne” campaign encourages...

September 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today presented data from a Phase 1 study of GEN-004, an investigational vaccine...

September 6, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, an immunotherapy company working to develop ValloVax™, the first cellular anti-angiogenic cancer vaccine, has announced today the appointment of Dr. Hong Ma as Chief Scientific Officer. Ma – who has...

September 5, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology has received Orphan Drug Designation from the U.S. Food and Drug Administration for its HART-Trachea

September 5, 2014

ST. LOUIS--(BUSINESS WIRE)--Mediomics has been awarded an SBIR phase II contract to develop effective methods to screen high affinity monoclonal antibodies to detect post-translational modifications of proteins

September 5, 2014

--(BUSINESS WIRE)--Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical,...

September 5, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTCD), a leader in the field of regenerative medicine, announced today that the US Patent and Trademark Office (USPTO) has issued U.S. patent 8,822,218 covering...

September 5, 2014

SAN ANTONIO--(BUSINESS WIRE)--KCI Partners with B. Braun Medical to sell Prontosan® Wound Irrigation Solution for use with V.A.C. VeraFlo™ Negative Pressure Wound Therapy

September 5, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Highlights Study Involving ARROW PICC with Chlorag+ard Technology, Showing Significant Reduction in PICC-Related Bloodstream Infections

September 5, 2014

TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS’ FOUNDER LEADS STUDY IDENTIFYING A NOVEL MECHANISM FOR TREATING INFLAMMATORY BOWEL DISEASE